| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.28 | 0.04 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.35 | 0.04 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |